Form D · Biotechnology

Angiex, Inc.

Cambridge, MA · CIK 0001710380

Offering snapshot reported Sep 26, 2025 · SEC filing

Reported sold
$22M
Offering amount: $28.4M
Investors reported
137
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 31, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$11M$22MAug 14, 2025: $10,980,030.00Aug 14, 2025Sep 26, 2025: $21,991,695.00Sep 26, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,980,030 → $21,991,695
  • Reported investors57 → 137

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 26, 2025Amendment$21,991,695$11,011,665vs Aug 14, 2025137SEC filing
Aug 14, 2025Initial$10,980,030No comparison57SEC filing
Jul 17, 2017Initial$2,880,022No comparison3SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$2.43M (estimated)
Form D file number
021-554765
Total amount sold include $2,877,002.24 of converted indebtedness and current interest; and $8,064,117.91 of aggregate value of Warrants to purchase common stock.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Paulson Investment Company, LLC567010220 SW Greenburg Road, Suite 380

Source: Form D, filed Sep 26, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jonathan Adams Director
Amal Amin Director
Errik Anderson Director
Jason Camm Director
Iain Dukes Director
Haijing Guo Director
Fabian Hansen Director
Paul Jaminet Director, Executive
Tina Neel Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
150 Cambridge Park Drive, 5th Floor
Cambridge, MA, 02140